Clinical trial
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer…
NCT00129142 · GTx, Industry · Completed
Key facts
| NCT number | NCT00129142 |
|---|---|
| Title | Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy |
| Official title | A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy |
| Lead sponsor | GTx, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Osteoporosis, Fractures |
| Intervention type | Drug |
| Interventions | Toremifene Citrate |
| Enrollment | 1,200 |
| Start date | Oct 1, 2003 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 11, 2005 |
| Last update posted | Nov 15, 2013 |
| Countries | Mexico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: